These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 9973273)

  • 21. Defective mRNA in myotonic dystrophy accumulates at the periphery of nuclear splicing speckles.
    Holt I; Mittal S; Furling D; Butler-Browne GS; Brook JD; Morris GE
    Genes Cells; 2007 Sep; 12(9):1035-48. PubMed ID: 17825047
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A functional deadenylation assay identifies human CUG-BP as a deadenylation factor.
    Paillard L; Legagneux V; Beverley Osborne H
    Biol Cell; 2003; 95(2):107-13. PubMed ID: 12799066
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biomedicine. Reconstructing myotonic dystrophy.
    Tapscott SJ; Thornton CA
    Science; 2001 Aug; 293(5531):816-7. PubMed ID: 11486078
    [No Abstract]   [Full Text] [Related]  

  • 24. In vivo co-localisation of MBNL protein with DMPK expanded-repeat transcripts.
    Fardaei M; Larkin K; Brook JD; Hamshere MG
    Nucleic Acids Res; 2001 Jul; 29(13):2766-71. PubMed ID: 11433021
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CUG repeat binding protein (CUGBP1) interacts with the 5' region of C/EBPbeta mRNA and regulates translation of C/EBPbeta isoforms.
    Timchenko NA; Welm AL; Lu X; Timchenko LT
    Nucleic Acids Res; 1999 Nov; 27(22):4517-25. PubMed ID: 10536163
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Myotonic dystrophy: discussion of molecular basis.
    Timchenko LT; Tapscott SJ; Cooper TA; Monckton DG
    Adv Exp Med Biol; 2002; 516():27-45. PubMed ID: 12611434
    [No Abstract]   [Full Text] [Related]  

  • 27. HNRNPA1-induced spliceopathy in a transgenic mouse model of myotonic dystrophy.
    Li M; Zhuang Y; Batra R; Thomas JD; Li M; Nutter CA; Scotti MM; Carter HA; Wang ZJ; Huang XS; Pu CQ; Swanson MS; Xie W
    Proc Natl Acad Sci U S A; 2020 Mar; 117(10):5472-5477. PubMed ID: 32086392
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular basis for impaired muscle differentiation in myotonic dystrophy.
    Timchenko NA; Iakova P; Cai ZJ; Smith JR; Timchenko LT
    Mol Cell Biol; 2001 Oct; 21(20):6927-38. PubMed ID: 11564876
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Short antisense-locked nucleic acids (all-LNAs) correct alternative splicing abnormalities in myotonic dystrophy.
    Wojtkowiak-Szlachcic A; Taylor K; Stepniak-Konieczna E; Sznajder LJ; Mykowska A; Sroka J; Thornton CA; Sobczak K
    Nucleic Acids Res; 2015 Mar; 43(6):3318-31. PubMed ID: 25753670
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Myotonic dystrophy as an RNA-mediated disease].
    Ishiura S
    Rinsho Shinkeigaku; 2005 Nov; 45(11):828-30. PubMed ID: 16447737
    [No Abstract]   [Full Text] [Related]  

  • 31. Altered expression of CUG binding protein 1 mRNA in myotonic dystrophy 1: possible RNA-RNA interaction.
    Watanabe T; Takagi A; Sasagawa N; Ishiura S; Nakase H
    Neurosci Res; 2004 May; 49(1):47-54. PubMed ID: 15099703
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MBNL1 and CUGBP1 modify expanded CUG-induced toxicity in a Drosophila model of myotonic dystrophy type 1.
    de Haro M; Al-Ramahi I; De Gouyon B; Ukani L; Rosa A; Faustino NA; Ashizawa T; Cooper TA; Botas J
    Hum Mol Genet; 2006 Jul; 15(13):2138-45. PubMed ID: 16723374
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Colocalization of muscleblind with RNA foci is separable from mis-regulation of alternative splicing in myotonic dystrophy.
    Ho TH; Savkur RS; Poulos MG; Mancini MA; Swanson MS; Cooper TA
    J Cell Sci; 2005 Jul; 118(Pt 13):2923-33. PubMed ID: 15961406
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The structural basis of myotonic dystrophy from the crystal structure of CUG repeats.
    Mooers BH; Logue JS; Berglund JA
    Proc Natl Acad Sci U S A; 2005 Nov; 102(46):16626-31. PubMed ID: 16269545
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Crystallization and preliminary X-ray analysis of RNA oligomers containing CUG repeats which induce type 1 myotonic dystrophy.
    Sato Y; Kimura K; Takénaka A
    Nucleic Acids Symp Ser (Oxf); 2004; (48):117-8. PubMed ID: 17150506
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The CUG-binding protein binds specifically to UG dinucleotide repeats in a yeast three-hybrid system.
    Takahashi N; Sasagawa N; Suzuki K; Ishiura S
    Biochem Biophys Res Commun; 2000 Oct; 277(2):518-23. PubMed ID: 11032753
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Effect on gene expression of the expanded CTG repeat on 3'-untranslated region of myotonic dystrophy (DM) protein kinase].
    Furuya H; Imai N; Shiokawa K; Kira J
    Nihon Rinsho; 1999 Apr; 57(4):932-6. PubMed ID: 10222793
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expanded CUG Repeats Trigger Disease Phenotype and Expression Changes through the RNAi Machinery in C. elegans.
    Qawasmi L; Braun M; Guberman I; Cohen E; Naddaf L; Mellul A; Matilainen O; Roitenberg N; Share D; Stupp D; Chahine H; Cohen E; Garcia SMDA; Tabach Y
    J Mol Biol; 2019 Apr; 431(9):1711-1728. PubMed ID: 30878478
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nuclear RNA foci in the heart in myotonic dystrophy.
    Mankodi A; Lin X; Blaxall BC; Swanson MS; Thornton CA
    Circ Res; 2005 Nov; 97(11):1152-5. PubMed ID: 16254211
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mechanisms of skeletal muscle wasting in a mouse model for myotonic dystrophy type 1.
    Morriss GR; Rajapakshe K; Huang S; Coarfa C; Cooper TA
    Hum Mol Genet; 2018 Aug; 27(16):2789-2804. PubMed ID: 29771332
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.